BioMed Research International

Mass Spectrometry Applications in Biomedical Research

Publishing date
26 Dec 2014
Submission deadline
08 Aug 2014

Lead Editor

1Department of Pathology, Albert Einstein College of Medicine, Bronx, New York 10461, USA

2School of Life Sciences, Tsinghua University, Beijing, China

3Division of Systems Biology, National Center for Toxicological Research, US FDA, Jefferson, AR 72079, USA

4Diabetes and Obesity Research Center, Sanford-Burnham Medical Research Institute at Lake Nona, Orlando, FL 32827, USA

Mass Spectrometry Applications in Biomedical Research


With the tremendous advances of modern mass spectrometry (MS) techniques, MS has become one of the essential analytical tools to biological and biomedical research. Mass spectrometry provides rapid and sensitive qualitative and quantitative analysis of biomolecules (proteins, peptides, oligosaccharides, lipids, DNA, and RNA), drugs, and metabolites. In combination with a variety of modern separation technologies, MS has been successfully applied to high-throughput proteomewide analysis of proteins, protein-protein interactions, and protein posttranslational modifications (PTMs) in cells, tissues, or organs. In the past several years, we have also witnessed fast growth in metabolomics and tissue imaging fueled by MS analysis. The wide implementation of MS certainly has resulted in and will continuously benefit in the advancement of indepth understanding of biological processes and their underlying molecular mechanisms. In terms of biomarker discovery for many human diseases and therapeutics, MS-based proteomics and metabolomics are playing an important role and the application of MS to clinical molecular diagnosis will be expected in the near future. Potential topics in a variety of method development and applications of MS in biological and biomedical research include, but are not limited to:

  • Proteome profile and/or quantitative proteomic studies (stable isotopic labeling, label free, and MRM)
  • Protein PTM characterization; Omics of PTMs (phosphoproteome, glycoproteome, acetylome, methylproteome, etc.)
  • MS-based biomarker discovery and/or validation
  • Metabolomics
  • MS in pharmacology and toxicology

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:

BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision128 days
Acceptance to publication21 days
Journal Citation Indicator-
Impact Factor-
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.